ArticleSleep & breathing = Schlaf & Atmung2026
Periodic limb movements of sleep and hypertension in patients with obstructive sleep apnea: a hypothesis-generating analysis from a polysomnographic cohort.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension in obstructive sleep apnea (OSA) is incompletely explained by intermittent hypoxia and respiratory events alone. Periodic limb movements of sleep (PLMS) induce repetitive nocturnal sympathetic activation and blood pressure surges, yet their contribution to established daytime hypertension in OSA is poorly characterised.
methodsIn a retrospective cohort of 60 PSG-confirmed OSA patients, participants were stratified by PLMS Index (PLMS-I) threshold of ≥ 15 events/hr. Hypertension prevalence, cardiovascular risk indices (Framingham Risk Score, FRS; Charlson Comorbidity Index, CCI), gender distribution, and polysomnographic parameters were compared between groups using chi-square, independent t-test, Mann-Whitney U test, and Spearman correlation. Binary logistic regression was performed with hypertension as the outcome variable and PLMS-I group, age, and gender as covariates. Partial Spearman correlations between PLMS-I and FRS/CCI were computed after controlling for age.
resultsPatients with PLMS-I ≥ 15/hr (n = 41) had a significantly higher hypertension prevalence than those with PLMS-I < 15/hr (n = 19): 76.7% vs. 23.3% of all hypertensive patients (p = 0.026). Gender distribution did not differ between groups (males: 70.7% vs. 57.9%; p = 0.326). On binary logistic regression adjusting for age and gender, high PLMS-I was associated with 2.4-fold increased odds of hypertension (OR = 2.421, 95% CI 0.640-9.161, p = 0.193), which did not reach statistical significance; age was an independent predictor (OR = 1.068/year, 95% CI 1.020-1.119, p = 0.005). PLMS-I correlated positively with FRS (r = 0.302, p = 0.023) and CCI (r = 0.346, p = 0.007); these associations were attenuated after partial correlation controlling for age (partial r = 0.146, p = 0.268 and partial r = 0.114, p = 0.391, respectively). The high-PLMS-I group demonstrated a significantly elevated arousal index (p = 0.001).
conclusionWhile high PLMS-I was associated with 2.4-fold increased odds of hypertension in OSA, this did not reach significance after age adjustment (OR = 2.421, p = 0.193), with age emerging as the primary predictor. Unadjusted correlations with FRS and CCI were attenuated after controlling for age. These hypothesis-generating findings highlight the confounding role of age and underscore the need for larger, adequately powered prospective studies to determine whether PLMS-I is a truly independent cardiovascular risk correlate in OSA.
Indexed as
Identifiers
42669746What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.